Literature DB >> 2188402

Synthetic peptide vaccines against pathogens and biological mediators.

G J Riveau1, F M Audibert.   

Abstract

Recent advances in immunology and biotechnology have opened the way for new approaches to vaccine design. Gilles Riveau and Françoise Audibert discuss progress in the design of synthetic peptide antigens for vaccines against pathogens, and discuss the possibility that such vaccines could also be used to control the activity of endogenous mediators.

Mesh：

Substances：

Year:  1990        PMID： 2188402     DOI： 10.1016/0165-6147(90)90114-n

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


  2 in total

1.  Production of polyclonal antibodies to feline tumor necrosis factor.

Authors:  C M Otto; F Niagro; R A McGraw; C A Rawlings
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Detection of antibodies to human immunodeficiency virus type I by using synthetic peptides and time-resolved fluoroimmunoassay (TR-FIA).

Authors:  V R Lombardi; O Libonatti; M Alimandi; I Ansotegui; G Scarlatti; V Moschese; H Wigzell; P Rossi
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.